(Q40480821)

English

Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

author name string

Kenneth V I Rolston

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Ellen F Manzullo

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Linda S Elting

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Susan E Frisbee-Hume

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Leslie McMahon

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Richard L Theriault

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Shreyaskumar Patel

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Robert S Benjamin

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2489-2494

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Bacterial infections in low-risk, febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

Fever and neutropenia clinical practice guidelines.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

21 January 2018

New trends in patient management: risk-based therapy for febrile patients with neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

7 January 2021

based on heuristic

inferred from DOI database lookup

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21908

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21908

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40480821&oldid=1786067111"